Nivolumab 100mg/10ml Injection from Canada
Nivolumab is a PD-1 inhibitor monoclonal antibody antineoplastic for melanoma and lung cancer, supplied in 100mg/10ml preservative-free vials. It meets HTS 3004.90.92.16 criteria for measured-dose immunosuppressive biologics.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• ,Use data loggers for full shipment temperature excursion proof